UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033371
Receipt number R000038042
Scientific Title Safety assessment of oral intake of L-Ornithine: Systematic review
Date of disclosure of the study information 2019/04/30
Last modified on 2021/11/21 11:53:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety assessment of oral intake of L-Ornithine: Systematic review

Acronym

Safety assessment of oral intake of L-Ornithine

Scientific Title

Safety assessment of oral intake of L-Ornithine: Systematic review

Scientific Title:Acronym

Safety assessment of oral intake of L-Ornithine

Region

Japan


Condition

Condition

Human who has received L-Ornithine by oral

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigate the tolerability of orally ingesting of L-ornithine.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

All of adverse events

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

All studies which are intervention of L-Orn oral intake in human.

Key exclusion criteria

We exclude studies that is not oral intake of L-Orn or not clinical study.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Kohsuke
Middle name
Last name Hayamizu

Organization

Yokohama University of Pharmacy

Division name

Laboratory of Food Chemistry

Zip code

245-0066

Address

601 Matano-cho, Totsuka-ku, Yokohama, Kanagawa, JAPAN

TEL

045-859-1300

Email

k.hayamizu@hamayaku.ac.jp


Public contact

Name of contact person

1st name Kohsuke
Middle name
Last name Hayamizu

Organization

Yokohama University of Pharmacy

Division name

Laboratory of Food Chemistry

Zip code

244-0066

Address

601 Matano-cho, Totsuka-ku, Yokohama, Kanagawa, JAPAN

TEL

045-859-1300

Homepage URL


Email

k.hayamizu@hamayaku.ac.jp


Sponsor or person

Institute

Yokohama University of Pharmacy

Institute

Department

Personal name



Funding Source

Organization

International Council on Amino Acid Science

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

meta-analysis

Address

meta-analysis

Tel

045-859-1300

Email

k.hayamizu@hayamizu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 04 Month 30 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

It was decided to suspend the project temporarily in order to improve the accuracy of the final results due to the information on the ongoing test regarding L-Orn.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2018 Year 04 Month 30 Day

Date of IRB

2018 Year 05 Month 10 Day

Anticipated trial start date

2018 Year 07 Month 13 Day

Last follow-up date

2019 Year 10 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Finished web based database search.
Under performing statistical analysis.

Interim analysis report finished


Management information

Registered date

2018 Year 07 Month 12 Day

Last modified on

2021 Year 11 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038042


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name